ABT530 T5127
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ABT-530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
CAS nr:
1353900-92-1
Purity:
98%
Molecular Weight:
1113,18
SMILES:
CO[C@H](C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1c1nc2cc(F)c(cc2[nH]1)[C@H]1CC[C@@H](N1c1cc(F)c(N2CCC(CC2)c2ccc(F)cc2)c(F)c1)c1cc2[nH]c(nc2cc1F)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC
Formula:
C57H65F5N10O8
Pathway:
Microbiology/Virology,Proteases/Proteasome
Target:
HCV Protease,HCV Protease
